Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Phoenix, Arizona


Purpose:

This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration to establish comparability between Japanese and non-Japanese.


Criteria:

Inclusion Criteria: - Diagnosis of wet age-related macular degeneration in at least 1 eye - Best corrected visual acuity of 20/32 to 20/320 in the study eye and 20/200 or better in the fellow eye Exclusion Criteria: - Hypersensitivity, allergy, or anaphylactic reaction to iodine - Cataract or refractive surgery within the last 3 months - History of vitrectomy


NCT ID:

NCT02181517


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.